Drug Topics October 27, 2024
Lauren Biscaldi, MS, Managing Editor

PBM reform legislation has progressed further in Congress than ever before.

Cole Schmidtknect was only 22 years old when he died.

In January, Cole—who had been diagnosed with severe asthma at age 1—went to the pharmacy to pick up the inhaler he used to manage his condition. There, he learned that his inhaler was no longer covered by his insurance; there was no alternative, and no generic option.

Five days later, Cole had a severe asthma attack. He went into cardiac arrest on the way to the hospital, spent 6 days in the intensive care unit, and died on January 21, 2024.

At the 2024 National Community Pharmacists Association (NCPA) Annual Convention and Expo,1 Cole’s father Bil Schmidtknect shared his...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin
What might a Trump administration mean for the Biosecure Act?

Share This Article